Zeteo Biomedical
  • Home
  • Routes of Delivery
    • Ophthalmic
    • Nasal/ Intranasal
    • Nose to Brain
    • Sublingual
    • Animal Care
  • Biosecurity
  • Services
    • Pre-Commercial
    • Commercial
  • Technology
    • Technology Platforms
    • Delivery Devices
    • Primary Containers
  • Resources
    • In the News
    • Partners
Select Page

Zeteo Biomedical To Present At SXSW Texas Global Health Security Innovation Demo Day Event

by Zeteo Biomedical | Mar 15, 2021 | Press Release

TEXGHS Global Health Security Event Features International Agenda of Companies and Speakers AUSTIN, TX – 15 March 2021 – Zeteo Biomedical will present its nasal vaccine packaging and delivery device technologies at the TEXGHS Global Health Security Demo Day scheduled...

Zeteo Biomedical Receives US Patent for Innovative Sublingual Delivery Device For Vaccines and Pharmaceuticals

by Zeteo Biomedical | Mar 10, 2021 | Press Release

Sublingual delivery is an emerging strategy for vaccines AUSTIN, TX – 10 March 2021 – Zeteo Biomedical a privately held, biomedical device company, announced today it has been awarded a United States Patent for its “Oral Delivery Device and Methods” (US Patent...

Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act Funded Program

by Zeteo Biomedical | Nov 17, 2020 | Press Release

A nasal vaccine that can be self-administered is crucial to protect global populations against pandemic virus threats AUSTIN, TX – 17 November 2020 –(send2press)– Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the...

Zeteo Biomedical Introduces ZEOx1 AquilaMD™ Ophthalmic Drug Delivery System

by Zeteo Biomedical | Jun 1, 2020 | Press Release

Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals AUSTIN, TX – 01 June 2020 — (PR.com) – Zeteo Biomedical LLC announced today the availability of the ZEOx1...

Zeteo Biomedical receives NIH Award to develop a universal nasal flu vaccine in collaboration with the Iowa State University Nanovaccine Institute

by Zeteo Biomedical | May 20, 2020 | Press Release

Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats AUSTIN, TX – 20 May 2020 –(pr.com)– Zeteo Biomedical LLC, Inc., a privately held, medical...
« Older Entries

Zeteo Biomedical LLC

PO Box 342216
Austin, Texas 78734 USA

Company Info

  • About us
  • Contact Us

Legal

  • PO Terms
  • Privacy Statement
  • Cookie policy (EU)
  • FCOI Policy

Zeteo logo
© Copyright 2021
Zeteo Biomedical LLC
All rights reserved